Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daniel O'Day
Pharma
Gilead boosts CEO O'Day's 2025 compensation by 20% to $28.4M
Gilead increased its pay to CEO Daniel O’Day by 20% in 2025, to $28.4 million, putting him among a group of the highest-paid CEOs in the industry.
Kevin Dunleavy
Mar 23, 2026 3:05pm
‘Pieces are coming together’ amid Gilead's Yeztugo launch: exec
Feb 11, 2026 11:34am
Fierce Biotech
JPM26: Gilead eyes new deals from a 'position of strength'
Jan 14, 2026 3:30am
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
Gilead bumps CEO Daniel O'Day's compensation package to $23.7M
Mar 28, 2025 10:47am
The top 10 best-paid CEOs in Big Pharma in 2023
Jun 17, 2024 3:00am
